Results 101 to 110 of about 8,414 (207)

Erythrocytosis in a patient on hemodialysis for thirteen years.

, 2006
Most hemodialysis patients exhibit renal anemia mainly due to erythropoietin deficiency as a result of impaired erythropoetin production in the kidney. However, erythrocytosis in patients with renal failure requiring hemodialysis is extremely rare.
KAYNAR, Kubra, Cobanoglu, Umit, GUL, Semih, AKDOGAN, Remzi, AKDOGAN, Elif, DILLI, Utku Donem, Ozdemir, FEYYAZ, Ulusoy, Sukru   +7 more
core  

Potential Link Between Janus Kinase 2 Mutation and Renal Artery Stenosis Leading to Refractory Secondary Hypertension - A Case Report

JK Science
Polycythaemia vera (PV) is a rare BCR/ABL negative chronic myeloproliferative neoplasm characterized by increased red cell mass, splenomegaly and JAK2 V617 mutation in nearly all patients.
Lakshmipriya V, Vanishree Murugavel, Jayaganesh   +2 more
doaj  

External Validation of the JAKPOT Score for Diagnosing JAK2-Positive Erythrocytosis: A Retrospective Cohort Study †

Background/Objectives: Erythrocytosis is a common laboratory abnormality affecting approximately 4% of males and 0.4% of females. The JAKPOT score was recently developed to differentiate primary from secondary erythrocytosis without molecular testing ...
Rajkumar, Sabina, Sabina Rajkumar, Mithoowani, Siraj, Wendy Lim, Rabia Tahir, Tahir, Rabia, Crowther, Mark, Justin Bruni Senecal, Lim, Wendy, Yasmine Madan, Mark Crowther, Madan, Yasmine, Senecal, Justin Bruni, Siraj Mithoowani   +13 more
core   +1 more source

Masked Triple-Negative Polycythemia Vera Initially Presenting as Iron Deficiency and Pernicious Anemia. [PDF]

Cureus
Nedjar OG, Palacio I, Israilov D, Kahook Z, Surksha MA, Wu A, Rodriguez AM, Inastrilla L, Michel G.   +8 more
europepmc   +1 more source

Sodium-glucose cotransporter 2 inhibitor-associated erythrocytosis in type 2 diabetes: a retrospective cohort study. [PDF]

Acta Diabetol
Baldassarre MPA, Carrieri F, Sablone A, Marotta A, Ranalli P, Febo F, Consoli A, Di Nicola M, Formoso G.   +8 more
europepmc   +1 more source

Familial erythrocytosis associated with an <i>EGLN1</i> (PHD2) variant of uncertain significance with emerging evidence of pathogenicity. [PDF]

BMJ Case Rep
Ananthaneni A, Maddox K, Sam R, Ramadas P.   +3 more
europepmc   +1 more source

SGLT2 inhibitors and secondary polycythemia: a systematic review and meta-analysis of hematologic effects in patients with type 2 diabetes. [PDF]

Eur J Clin Pharmacol
Ali EAH, Rabadi M, Aweer RA, Subahi E, Abdelmahmuod EA, Alshurafa A, Abdulgayoom M, Mudarres MF, Elshaikh U, Al-Mashdali A, Mohamed S.   +10 more
europepmc   +1 more source

Post-Treatment Persistent Erythrocytosis in Patients with Hodgkin Lymphoma: Molecular Mechanisms Underlying the Pathogenesis of Erythrocytosis. [PDF]

Cancers (Basel)
Koyun D, Yüksel S, Civriz Bozdağ S, Tuncalı T, Kuzu I, Özcan M.   +5 more
europepmc   +1 more source

Hemoglobin Trajectories on SGLT2 Inhibitor Therapy in Heart Failure: Anemia Marks Adverse Prognosis While Erythrocytosis Is Transient and Not Associated with Adverse Outcomes. [PDF]

J Clin Med
Jurin I, Hadžibegović I, Pavlov M, Marović M, Čikara T, Lucijanić M.   +5 more
europepmc   +1 more source

Excessive erythrocytosis and the hypertensive phenotype at high altitude: emerging evidence and unresolved questions. [PDF]

Front Cardiovasc Med
Li Y, Ma J, Zhang X, Zhang J, Chen X.
europepmc   +1 more source